With respect to hBD-2 concentration, the positive regulatory role exerted by IL-17 on hBD-2 has been demonstrated; for example, high levels of hBD-2 correlate with low IL-17A levels and increased severity of psoriasis and/or RA [16]. This evidence concerns the gene IL17A and rheumatoid arthritis.